DaraxONRASib

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

DaraxONRASib

Mar 27, 2025, 14:20 | Blog

New treatments for advanced/metastatic RAS-mutated NSCLC presented at ELCC25 - ESMO

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Clinical Trials presented…

Jan 28, 2025, 08:26 | Blog

Elvina Almuradova: Promising results with Daraxonrasib in RAS-mutant PDAC

Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, posted the following on LinkedIn: “Daraxonrasib (RMC-6236), an…

Jan 15, 2025, 14:22 | Blog

Anirban Maitra: The Revolution Medicines siblings

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023